Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

Comments

Post a Comment

Popular posts from this blog

Hyd rain: Getting rid of flood water proves costly

Image
Over a week after heavy rains lashed the city and flooded several areas, colonies in different parts of the city are still struggling to get rid of the muddy water and sewage that inundated their homes by spending hundreds of rupees every day. from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/35zbEK7
Read more